Question of the Day

Question of the Day – Friday January 20, 2017

Question: Individuals requiring chronic transfusion therapy are often treated with the iron chelator deferoxamine in order to address transfusion-induced hemochromatosis and associated complications. Which toxicities have been associated with the use of deferoxamine?

View full post for answer.